The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Screening for cervical cancer: a systematic review and meta-analysis
Open accessAbstract
BACKGROUND: The systematic review on which this paper is based provided evidence for the Canadian Task Force on Preventive Health Care to update their guideline regarding screening for cervical cancer. In this article we highlight three questions covered in the full review that pertain to the effectiveness of screening for reducing cervical cancer mortality and incidence as well as optimal timing and frequency of screening. METHODS: We searched MEDLINE, Embase and Cochrane Central from 1995 to 2012 for relevant randomized controlled trials and observational studies with comparison groups. Eligible studies included women aged 15 to 70 years who were screened using conventional cytology, liquid-based cytology or human papillomavirus DNA tests. Relevance screening, data extraction, risk of bias analyses and quality assessments were performed in duplicate. We conducted a meta-analysis using a random-effects model on the one body of evidence that could be pooled. RESULTS: From the 15,145 screened citations, 27 papers (24 studies) were included; five older studies located in a United States Preventive Services Task Force review were also included. A randomized controlled trial in India showed even a single lifetime screening test significantly decreased the risk of mortality from and incidence of advanced cervical cancer compared to no screening (mortality: risk ratio 0.65, 95% confidence interval 0.47, 0.90; incidence: relative risk 0.56, 95% confidence interval 0.42, 0.75). Cytology screening was shown to be beneficial in a cohort study that found testing significantly reduced the risk of being diagnosed with invasive cervical cancer compared to no screening (risk ratio 0.38; 95% confidence interval 0.23, 0.63). Pooled evidence from a dozen case-control studies also indicated a significant protective effect of cytology screening (odds ratio 0.35; 95% confidence interval 0.30, 0.41). This review found no conclusive evidence for establishing optimal ages to start and stop cervical screening, or to determine how often to screen; however the available data suggests substantial protective effects for screening women 30 years and older and for intervals of up to five years. CONCLUSIONS: The available evidence supports the conclusion that cervical screening does offer protective benefits and is associated with a reduction in the incidence of invasive cervical cancer and cervical cancer mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
(2014) · Medical Entomology and Zoology · Cited by 17,633
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
GRADE guidelines: 5. Rating the quality of evidence—publication bias
Guyatt, G. H., Oxman, A. D., Montori, V., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Djulbegovic, B., Atkins, D., Falck-Ytter, Y., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.011 · Cited by 1,819
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Disorders of motility and muscle tone with special reference to the corpus striatum
Wilson, S. A. K. (1925) · The Lancet · Cited by 1,409
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,321
Review papers : The statistical basis of meta-analysis
Fleiss, J. (1993) · Statistical Methods in Medical Research · doi:10.1177/096228029300200202 · Cited by 1,281
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,123
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 837
Sterne, J. A., Egger, M., & Moher, D. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch10 · Cited by 651
Sasieni, P., Castanon, A., & Cuzick, J. (2009) · BMJ · doi:10.1136/bmj.b2968 · Cited by 399
Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden
Andrae, B., Kemetli, L., Sparen, P., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., & Tornberg, S. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn099 · Cited by 363
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
Sasieni, P., Adams, J., & Cuzick, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600974 · Cited by 332
The National Co-ordinating Network for Cervical Screening Working Group, Sasieni, P., Cuzick, J., & Lynch-Farmery, E. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.196 · Cited by 292
Strategies for global control of cervical cancer
Pontén, J., Adami, H., Bergström, R., Dillner, J., Friberg, L., Gustafsson, L., Miller, A. B., Parkin, D. M., Sparén, P., & Trichopoulos, D. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600102 · Cited by 289
DOES SCREENING BY "PAP" SMEARS HELP PREVENT CERVICAL CANCER?
Clarke, E. A., & Anderson, T. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90172-7 · Cited by 250
Recommendations on screening for cervical cancer
Canadian Task Force on Preventive Health Care (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121505 · Cited by 237
Sasieni, P., & Adams, J. (1999) · BMJ · doi:10.1136/bmj.318.7193.1244 · Cited by 176
Organised vs. spontaneous pap-smear screening for cervical cancer: A case-control study
Nieminen, P., Kallio, M., Anttila, A., & Hakama, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<55::aid-ijc11>3.0.co;2-u · Cited by 159
Zappa, M., Visioli, C. B., Ciatto, S., Iossa, A., Paci, E., & Sasieni, P. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601754 · Cited by 105
Screening for Cervical Cancer in Latin America: A Case-Control Study
Herrero, R., Brinton, L. A., Reeves, W. C., Brenes, M. M., de Britton, R. C., Gaitán, E., & Tenorio, F. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.6.1050 · Cited by 97
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands
van der Aa, M. A., Pukkala, ., Coebergh, J. W. W., Anttila, A., & Siesling, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.23276 · Cited by 95
Ogilvie, G. S., van Niekerk, D. J., Krajden, M., Martin, R. E., Ehlen, T. G., Ceballos, K. M., Peacock, S. J., Smith, L., Kan, L., Cook, D. A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-111 · Cited by 93
The impact of vaginal cytology on cervical cancer risks in cali, Colombia
Aristizabal, N., Cuello, C., Correa, P., Collazos, T., & Haenszel, W. M. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340103 · Cited by 92
Hernández‐Ávila, M. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.3.370 · Cited by 79
Limited Pap screening associated with reduced risk of cervical cancer in South Africa
Hoffman, M., Cooper, D. D., Carrara, H., Rosenberg, L. A., Kelly, J. P., Stander, I. A., Williamson, A., Denny, L., Toit, G. D., & Shapiro, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg081 · Cited by 49
Yang, B., Morrell, S. L., Zuo, Y., Roder, D. M., Tracey, E. A., & Jelfs, P. L. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9118-9 · Cited by 46
Herbert, A., Stein, K. B., Bryant, T. N., et al. (1996) · Journal of Medical Screening · doi:10.1177/096914139600300307 · Cited by 36
Decker, K., Demers, A. A., Chateau, D. G., Musto, G., Nugent, Z. J., Lotocki, R. J., & Harrison, M. (2009) · PubMed Central · Cited by 29
Vesco, K. K., Whitlock, E. P., Eder, M. L., Lin, J. S., Burda, B. U., Senger, C. A., Holmes, R. S., Fu, R. F., & Zuber, S. P. (2017) · Cited by 29
Hakama, M. (2012) · Statistics in the health sciences · doi:10.1007/978-1-4614-5586-8_15 · Cited by 15
Evaluation of the nationwide cervical screening programme in Thailand: a case-control study
Kasinpila, C., Promthet, S. S., Vatanasapt, P., Sasieni, P. D., & Parkin, D. M. (2011) · Journal of Medical Screening · doi:10.1258/jms.2011.011075 · Cited by 14
Hakama, M. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1265-9_4 · Cited by 10
McMaster Evidence Review and Synthesis Centre
Neary, J., Hammill, A., Rice, M., Gauld, M., Canada, H. O., & Lindsay, P. (2010) · Cited by 1
Cited by
Evidence for overuse of medical services around the world
Brownlee, S., Chalkidou, K., Doust, J., Elshaug, A. G., Glasziou, P., Heath, I., Nagpal, S., Saini, V., Srivastava, D., Chalmers, K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32585-5 · Cited by 1,149
Chan, C. K., Aimagambetova, G., Ukybassova, T., Kongrtay, K., & Azizan, A. (2019) · Journal of Oncology · doi:10.1155/2019/3257939 · Cited by 494
Cervical Cancer Screening: A Review
Perkins, R. B., Wentzensen, N., Guido, R. S., & Schiffman, M. (2023) · JAMA · doi:10.1001/jama.2023.13174 · Cited by 492
The IARC Perspective on Cervical Cancer Screening
Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., Kupets, R., Smith, R., Arrossi, S., Bendahhou, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmsr2030640 · Cited by 357
Jansen, E. E. L., Zielonke, N., Gini, A., Anttila, A., Segnan, N., Vokó, Z., Ivanuš, U., McKee, M., de Koning, H. J., de Kok, I. M. C. M., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.12.013 · Cited by 258
Metadata
- Authors
- Peirson, L., Fitzpatrick-Lewis, D., Ciliska, D., & Warren, R.
- Venue
- Systematic Reviews
- Published
- 2013-05-24
- Volume
- 2
- Issue
- 1
- Pages
- 35-35
- ISSN
- 2046-4053 (ISSN-L)
- OpenAlex
- W2124219054
- Cited by
- 431
- References
- 38
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.